Anticoagulation Reversal for ICH

June 24, 2019 00:26:09
Anticoagulation Reversal for ICH
Critical Care Perspectives in Emergency Medicine
Anticoagulation Reversal for ICH

Jun 24 2019 | 00:26:09

/

Show Notes

ICH accounts for approximately 15 percent of all strokes.  Despite improvements in neurocritical care, the mortality for patients with ICH can still reach 50 percent at 1-year, with many left with significant residual deficits.  Patients with an ICH who are taking an oral anticoagulant medication tend to have larger ICH volumes, more frequent IVH, and a greater frequency of hematoma expansion.  In this podcast, we review the latest recommendations on reversing anticoagulant medications in patients with an ICH. This is information you can’t afford to miss!

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode

July 07, 2025 00:21:54
Episode Cover

Dexmedetomidine or Propofol for Sedation in the Critically Ill?

Critically ill patients receiving mechanical ventilation require analgesia and sedation.  At present, propofol remains the most widely used sedative for intubated/ventilated patients.  Recent trials...

Listen

Episode 0

January 21, 2022 00:41:39
Episode Cover

Bicarbonate Therapy in the Critically Ill Patient

In this podcast we are joined by EM/CCM superstars Dr. Gabe Wardi and Dr. Kit Tainter, who discuss the physiologic effects of metabolic acidosis,...

Listen

Episode 0

September 16, 2021 00:29:18
Episode Cover

The TOMAHAWK Study

The COACT trial demonstrated no improvement in 90-day mortality for post-arrest patients without evidence of an ST-segment elevation MI who were randomized to immediate...

Listen